David R. Gagnon, MD, PhDAssociate Professor, Biostatistics
BiographyDavid Gagnon, MD MPH PhD is Associate Professor of Biostatistics. Dr. Gagnon is a biostatistician for the Framingham Foot Study and a senior biostatistician for the Massachusetts Veterans Epidemiology Research and Information Center [MAVERIC] located at the Boston VA hospital. He currently teaches Categorical Data Analysis [BS821], Advanced Methods in Statistical Computing [BS822] and Applications of Statistical Methods in Clinical Research [BS775]. Dr Gagnon’s research interests are in the areas of pharmacoepidemiology, longitudinal data analysis, survival analysis and statistical computing.
- Saint Anselm College, BA
- Tufts University, MD
- Boston University, MPH
- Boston University School of Public Health, PhD
- Published on 3/1/2014
Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily Step Count Is Associated With Plasma C-Reactive Protein and IL-6 in a US Cohort With COPD. Chest. 2014 Mar 1; 145(3):542-50.
- Published on 2/20/2014
Hermos JA, Quach L, Gagnon DR, Weber HC, Altincatal A, Cho K, Lawler EV, Grotzinger KM. Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):480-8.
- Published on 2/19/2014
Cho K, Gagnon DR, Driver JA, Altincatal A, Kosik N, Lanes S, Lawler EV. Dementia Coding, Workup, and Treatment in the VA New England Healthcare System. Int J Alzheimers Dis. 2014; 2014:821894.
- Published on 2/1/2014
Moy ML, Teylan M, Danilack VA, Gagnon DR, Garshick E. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Feb; 11(2):149-57.
- Published on 1/1/2014
Doherty AL, Battaglino RA, Donovan J, Gagnon D, Lazzari AA, Garshick E, Zafonte R, Morse LR. Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res. 2014 Jan; 29(1):251-9.
- Published on 12/1/2013
Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97.
- Published on 9/6/2013
Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013 Nov; 54(11):1997-2004.
- Published on 4/4/2013
Moy ML, Teylan M, Weston NA, Gagnon DR, Garshick E. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013; 8(4):e60400.
- Published on 2/15/2013
Reichmann WM, LaValley MP, Gagnon DR, Losina E. Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trials. BMC Med Res Methodol. 2013; 13:21.
- Published on 1/1/2013
Nguyen US, Dufour AB, Positano RG, Dines JS, Dodson CC, Gagnon DG, Hillstrom HJ, Hannan MT. The occurrence of ipsilateral or contralateral foot disorders and hand dominance: the framingham foot study. J Am Podiatr Med Assoc. 2013 Jan-Feb; 103(1):16-23.
View 78 more publications:View full profile at BUMC